Concepedia
Statistics
Publications
6
Citations
191
H-Index
Active since
2006
Affiliations
University of Miami(Current)
Augusta University Health
Charlie Norwood VA Medical Center
James J. Hoy is an author at University of Miami specializing in cell signaling, oncology, and cancer cell signaling.
Publications per year
2006–2020
Protein kinase A inhibitor proteins (PKIs) divert GPCR‐Gαs‐cAMP signaling toward EPAC and ERK activation and are involved in tumor growth
James J. Hoy, Natalia Salinas Parra, Jeannie Park et al. · The FASEB Journal · 2020 · 53 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer
Georgios Kallifatidis, Diandra K. Smith, Daley S. Morera et al. · Molecular Cancer Therapeutics · 2019 · 43 citations · Full text
Medicine, Cancer Biology, Oncology +16
β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation
Georgios Kallifatidis, Daniel Muñoz, Rajendra K. Singh et al. · Molecular Cancer Research · 2016 · 36 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Hydroxyacetone (CH<sub>3</sub>COCH<sub>2</sub>OH): A Combined Microwave and Millimeter‐Wave Laboratory Study and Associated Astronomical Search
A. J. Apponi, James J. Hoy, D. T. Halfen et al. · The Astrophysical Journal · 2006 · 28 citations
Natural Sciences, Astronomy, Chemistry +15
Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
James J. Hoy, Georgios Kallifatidis, Diandra K. Smith et al. · Scientific Reports · 2017 · 21 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–5 of 6